Straughn AB

References (3)

Title : Drug Regimen Individualization for Attention-Deficit\/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate Formulations - Patrick_2019_Pharmacotherapy_39_677
Author(s) : Patrick KS , Radke JL , Raymond JR , Koller L , Nguyen LV , Rodriguez W , Straughn AB
Ref : Pharmacotherapy , 39 :677 , 2019
Abstract :
PubMedSearch : Patrick_2019_Pharmacotherapy_39_677
PubMedID: 30351459

Title : Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers - Zhu_2017_J.Clin.Psychopharmacol_37_419
Author(s) : Zhu HJ , Patrick KS , Straughn AB , Reeves OT, 3rd , Bernstein H , Shi J , Johnson HJ , Knight JM , Smith AT , Malcolm RJ , Markowitz JS
Ref : J Clin Psychopharmacol , 37 :419 , 2017
Abstract :
PubMedSearch : Zhu_2017_J.Clin.Psychopharmacol_37_419
PubMedID: 28590363

Title : Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans - Patrick_2013_Drug.Metab.Dispos_41_197
Author(s) : Patrick KS , Straughn AB , Reeves OT, 3rd , Bernstein H , Bell GH , Anderson ER , Malcolm RJ
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 41 :197 , 2013
Abstract :
PubMedSearch : Patrick_2013_Drug.Metab.Dispos_41_197
PubMedID: 23104969